Josh Brumm
Equibles does not estimate personal net worth.
About Josh Brumm
Josh Brumm is recorded as CEO at Dyne Therapeutics, Inc. (DYN). The proxy statement of Dyne Therapeutics, Inc. reports total compensation of $14,383,011 for Josh Brumm in fiscal 2024, including a base salary of $156,027. Disclosed compensation is on record for 3 fiscal years. Dyne Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dyne Therapeutics, Inc. includes John Cox (CEO and Board Member), John G. Cox (CEO and Board Member), Erick Lucera (CFO and Chief Accounting Officer) and 4 others.
Affiliation history
-
Current
Company network
Leadership on record at Dyne Therapeutics, Inc.
- John Cox CEO, Board Member
- John G. Cox CEO, Board Member
- Erick Lucera CFO, Chief Accounting Officer
- Barry E. Greene Board Member
- Brian Posner Board Member
- Carlo Incerti, M.D. Board Member
- Vikram Karnani Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Dyne Therapeutics, Inc. (DYN) | Former President and Chief Executive Officer | $156,027 | $14,383,011 |
| 2023 | Dyne Therapeutics, Inc. (DYN) | Former President and Chief Executive Officer | $643,550 | $5,974,491 |
| 2022 | Dyne Therapeutics, Inc. (DYN) | Former President and Chief Executive Officer | $610,000 | $4,317,103 |
Recent activity
No call appearances or filed executive changes recorded yet.